| Brad Henry Goodman, M D | |
|
505 Eisenhower Dr, Savannah, GA 31406-2668 | |
| (912) 354-6190 | |
| (912) 354-6172 |
| Full Name | Brad Henry Goodman |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 32 Years |
| Location | 505 Eisenhower Dr, Savannah, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407816432 | NPI | - | NPPES |
| G38780 | Medicaid | SC | |
| 000762022E | Medicaid | GA | |
| 030004120 | Other | RAILROAD MEDICARE | |
| 768017 | Other | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 38780 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Allergy And Asthma Pc | 3971590050 | 6 |
News Archive
A team of researchers at the IRCM led by François Robert, PhD, uncovered a critical role for two proteins in chromatin structure. Their breakthrough, recently published in the scientific journal Molecular Cell, helps explain how DNA is organized in our cells. This discovery could lead to a better understanding of what causes certain types of cancer, such as lymphoma.
Genetics may make some women more vulnerable to the pressure of being thin, a study published in the International Journal of Eating Disorders has found. From size-zero models to airbrushed film stars, thinness is portrayed as equaling beauty across Western culture, and it's an ideal often cited as a cause of eating disorder symptoms in young women.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch this year for the treatment of asthma, Merck's formoterol/mometasone will garner peak year sales of more than $250 million in the United States, France, Germany, Italy, Spain and the United Kingdom.
Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.
› Verified 5 days ago
| Entity Name | Coastal Allergy & Asthma Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992742845 PECOS PAC ID: 3971590050 Enrollment ID: O20040429000886 |
News Archive
A team of researchers at the IRCM led by François Robert, PhD, uncovered a critical role for two proteins in chromatin structure. Their breakthrough, recently published in the scientific journal Molecular Cell, helps explain how DNA is organized in our cells. This discovery could lead to a better understanding of what causes certain types of cancer, such as lymphoma.
Genetics may make some women more vulnerable to the pressure of being thin, a study published in the International Journal of Eating Disorders has found. From size-zero models to airbrushed film stars, thinness is portrayed as equaling beauty across Western culture, and it's an ideal often cited as a cause of eating disorder symptoms in young women.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch this year for the treatment of asthma, Merck's formoterol/mometasone will garner peak year sales of more than $250 million in the United States, France, Germany, Italy, Spain and the United Kingdom.
Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brad Henry Goodman, M D 505 Eisenhower Dr, Savannah, GA 31406-2668 Ph: (912) 354-6190 | Brad Henry Goodman, M D 505 Eisenhower Dr, Savannah, GA 31406-2668 Ph: (912) 354-6190 |
News Archive
A team of researchers at the IRCM led by François Robert, PhD, uncovered a critical role for two proteins in chromatin structure. Their breakthrough, recently published in the scientific journal Molecular Cell, helps explain how DNA is organized in our cells. This discovery could lead to a better understanding of what causes certain types of cancer, such as lymphoma.
Genetics may make some women more vulnerable to the pressure of being thin, a study published in the International Journal of Eating Disorders has found. From size-zero models to airbrushed film stars, thinness is portrayed as equaling beauty across Western culture, and it's an ideal often cited as a cause of eating disorder symptoms in young women.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch this year for the treatment of asthma, Merck's formoterol/mometasone will garner peak year sales of more than $250 million in the United States, France, Germany, Italy, Spain and the United Kingdom.
Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.
› Verified 5 days ago
Dr. Stephen Gregory Hendrix, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1326 Eisenhower Dr, Bldg. 2, Savannah, GA 31406 Phone: 912-527-5270 Fax: 912-527-5279 | |
Dr. Jennifer Kay Appleyard, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 505 Eisenhower Dr, Savannah, GA 31406 Phone: 912-354-6190 Fax: 912-354-6172 | |
Monica Rama Kenney, M. D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 505 Eisenhower Dr, Savannah, GA 31406 Phone: 912-354-6190 Fax: 912-354-6172 | |
Bruce Daniel Finkel, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 505 Eisenhower Dr, Savannah, GA 31406 Phone: 912-354-6190 Fax: 912-354-6172 |